Conflicts of interest and industry funding declared in systematic reviews of interventions for six common diagnoses.

ABSTRACT:

Background

There is a lack of data on the prevalence of conflicts of interest (COI) declared in systematic reviews over time.

Methods

PubMed was searched for systematic reviews on interventions for chronic obstructive pulmonary disease, type 2 diabetes mellitus, hypertension, dementia, major depression, and osteoarthritis from 2010 and 2019. Selection was conducted by two independent authors, with disagreements resolved in consensus. COI and funding disclosures were extracted. COI were categorised using a specific framework.

Results

746 systematic reviews were included. One third involved pharmacological interventions. Systematic reviews from China increased from 4% to 21% between 2010 and 2019; Cochrane reviews decreased from 19% to 4%.Systematic reviews presenting a

SUBMITTER: Czajkowski M 

PROVIDER: S-EPMC12918370 | biostudies-literature | 2026 Dec

REPOSITORIES: biostudies-literature